Literature DB >> 19858395

Evidence-based approach to the introduction of positron emission tomography in ontario, Canada.

William K Evans1, Andreas Laupacis, Karen Y Gulenchyn, Les Levin, Mark Levine.   

Abstract

PURPOSE: The uptake of new health care technologies is usually driven by industry promotion, physician interest, patient demand, and institutional ability to acquire the technology. The introduction of positron emission tomography (PET) scanning in the province of Ontario, Canada, followed a different path.
METHODS: The Ontario provincial government, through its Ministry of Health and Long-Term Care, commissioned a systematic review of the literature. When this found only weak evidence that PET has a positive impact on clinical outcomes, the Ministry introduced a provincial PET evaluation program to close the evidence gap.
RESULTS: This article describes the challenges encountered establishing the PET evaluation program. These included the design and conduct of the initial clinical trials, the establishment of a PET cancer registry, standardizing how PET scans were performed and reported, and gaining acceptance by health professionals for the evaluative program.
CONCLUSION: The proliferation of health technologies is a key driver of increasing health care costs. The Ontario approach to the introduction of PET is a model worth consideration by health systems seeking to ensure that they receive value for money based on a strong evidentiary base when introducing new health technologies.

Entities:  

Mesh:

Year:  2009        PMID: 19858395     DOI: 10.1200/JCO.2009.22.1614

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  5 in total

1.  Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study.

Authors:  Christopher M Booth; Frances A Shepherd; Yingwei Peng; Gail E Darling; Gavin Li; Weidong Kong; William J Mackillop
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

2.  An assessment of the characteristics and quality of diagnostic accuracy studies for positron emission tomography conducted in Japan: a systematic review.

Authors:  Shuhei Nomura; Akinori Hisashige; Daisuke Yoneoka; Mikiko Kanda; Karin Miyamoto; Miwako Segawa; Erika Ota; Kenji Shibuya
Journal:  EJNMMI Res       Date:  2015-02-19       Impact factor: 3.138

3.  (18)F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer.

Authors:  J J You; K J Cline; C-S Gu; K I Pritchard; I S Dayes; K Y Gulenchyn; R I Inculet; S K Dhesy-Thind; M A Freeman; A M Chan; J A Julian; M N Levine
Journal:  Br J Cancer       Date:  2015-05-05       Impact factor: 7.640

4.  Setting a research agenda for medical overuse.

Authors:  Daniel J Morgan; Shannon Brownlee; Aaron L Leppin; Nancy Kressin; Sanket S Dhruva; Les Levin; Bruce E Landon; Mark A Zezza; Harald Schmidt; Vikas Saini; Adam G Elshaug
Journal:  BMJ       Date:  2015-08-25

5.  Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer: A Randomized Clinical Trial.

Authors:  Lorraine M Elit; Anthony W Fyles; Chu-Shu Gu; Gregory R Pond; David D'Souza; Rajiv Samant; Margaret Anthes; Gillian Thomas; Marc Filion; Julie Arsenault; Ian Dayes; Timothy J Whelan; Karen Y Gulenchyn; Ur Metser; Kavita Dhamanaskar; Mark N Levine
Journal:  JAMA Netw Open       Date:  2018-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.